Scientific Validity Reports for In Vitro Diagnostic Regulation

This white paper provides a comprehensive analysis of the European Union's In Vitro Diagnostic Regulation (IVDR) and its implications for manufacturers of in vitro diagnostics (IVDs). It outlines the significant changes introduced by the IVDR compared to the previous In Vitro Diagnostic Directive (IVDD), emphasizing the necessity for clinical and scientific evidence to support the validity of IVDs. The document details the role of systematic literature reviews (SLR) and systematic evidence reviews (SER) as essential components in establishing scientific validity and clinical performance. Furthermore, it introduces the Scientific Validity Report (SVR), which is now a mandatory element of the documentation required for regulatory compliance. The paper discusses the transition timelines for compliance and the classification of IVDs based on risk levels, highlighting the importance of adhering to these new requirements to ensure patient safety and continued market access in Europe.